GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shandong Boan Biotechnology Co Ltd (HKSE:06955) » Definitions » Other Stockholders Equity

Shandong Boan Biotechnology Co (HKSE:06955) Other Stockholders Equity : HK$122.8 Mil (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Shandong Boan Biotechnology Co Other Stockholders Equity?

Shandong Boan Biotechnology Co's Other Stockholders Equity for the quarter that ended in Dec. 2023 was HK$122.8 Mil.

Shandong Boan Biotechnology Co's quarterly Other Stockholders Equity increased from Dec. 2022 (HK$101.3 Mil) to Jun. 2023 (HK$115.5 Mil) and increased from Jun. 2023 (HK$115.5 Mil) to Dec. 2023 (HK$122.8 Mil).

Shandong Boan Biotechnology Co's annual Other Stockholders Equity declined from Dec. 2021 (HK$1,289.5 Mil) to Dec. 2022 (HK$101.3 Mil) but then increased from Dec. 2022 (HK$101.3 Mil) to Dec. 2023 (HK$122.8 Mil).


Shandong Boan Biotechnology Co Other Stockholders Equity Historical Data

The historical data trend for Shandong Boan Biotechnology Co's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Boan Biotechnology Co Other Stockholders Equity Chart

Shandong Boan Biotechnology Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Other Stockholders Equity
144.14 1,289.49 101.30 122.77

Shandong Boan Biotechnology Co Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Other Stockholders Equity Get a 7-Day Free Trial 1,289.49 1,066.66 101.30 115.49 122.77

Shandong Boan Biotechnology Co Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity


Shandong Boan Biotechnology Co Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Shandong Boan Biotechnology Co's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Shandong Boan Biotechnology Co (HKSE:06955) Business Description

Traded in Other Exchanges
Address
No. 39 Keji Avenue, High-Tech Industrial Development Zone, Shandong Province, Yantai, CHN
Shandong Boan Biotechnology Co Ltd is a fully integrated biopharmaceutical company. The company is engaged in the development, manufacture, and commercialization of high-quality biologics in China and around the world. It focuses on areas such as oncology, metabolism, autoimmunity, and ophthalmology. Geographically company's revenue is generated from customers located in Mainland China.
Executives
Asiapharm Investments Ltd.
Ginkgo (ptc) Limited
Liu Dianbo
Luye Life Sciences Group Ltd
Luye Pharma Holdings Ltd.
Luye Pharma Hong Kong Limited
Luye Pharmaceutical International Co., Ltd.
Luye Pharmaceutical Investment Co., Ltd.
Nelumbo Investments Limited
Shorea Lbg
Luye Pharma Group Ltd.
Shan Dong Lv Ye Zhi Yao You Xian Gong Si
Yan Tai Lv Ye Yi Yao Kong Gu Ji Tuan You Xian Gong Si
Li Li 2201 Interest of corporation controlled by you

Shandong Boan Biotechnology Co (HKSE:06955) Headlines

No Headlines